The Lung Metastasis Risk (LMR) Signature: A Prognostic Genomic Biomarker Predicting Distant Failure Among Stage I Adenocarcinoma Patients Following Local Therapy. - Kim, S.; Chen, D.T.; Stone, B.M.; Al-Rashdan, A.F.; Elsaka, R.; Torres-Roca, J.F.; Haura, E.; Dilling, T.J.; Robinson, L.; Stevens, C.W. (International Journal of Radiation Oncology, Biology, Physics, 2015)